Status:
NOT_YET_RECRUITING
Assessment of Diastolic Function During the Transitional Period and Infancy Using Serial Echocardiography
Lead Sponsor:
University College Cork
Conditions:
Diastolic Dysfunction
Neonatal Encephalopathy
Eligibility:
All Genders
6-18 years
Brief Summary
The goal of this single-centre longitudinal observational study is to create reference values for diastolic function parameters in neonates born at 35 weeks' gestation or above, and to assess the infl...
Detailed Description
Participants will have their first echo to assess diastolic function, using both conventional and novel echocardiographic measure, within the first 6 to 18 hours of life approximately (Day 1 scan) and...
Eligibility Criteria
Inclusion
- Birth at 35 weeks gestation or above
- Informed consent obtained
Exclusion
- Any apparent congenital anomalies
- Any known chromosomal abnormalities (except Trisomy 21)
- Any known congenital structural heart disease (except patent ductus arteriosus, atrial septal defect, patent foramen ovale or ventricular septal defect)
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06200519
Start Date
January 1 2024
End Date
July 1 2026
Last Update
January 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cork University Maternity Hospital
Cork, Ireland, T12 DC4A